ACADIA Pharmaceuticals Inc. (ACAD)
USD 14.91
(2.33%)
USD 14.91
(2.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 16.7 Million | -114.03 Million | -125.66 Million | -136.16 Million | -151.13 Million | -167.47 Million |
| Net Income | -61.28 Million | -215.97 Million | -167.87 Million | -281.58 Million | -235.25 Million | -245.19 Million |
| Depreciation & Amortization | 5.55 Million | 2.02 Million | 3.34 Million | 2.93 Million | 2.76 Million | 3 Million |
| Deferred income taxes | -140.8 Million | - | - | 2.74 Million | - | - |
| Stock-based compensation | 66.42 Million | 68.2 Million | 63.61 Million | 84.42 Million | 82.26 Million | 81.56 Million |
| Change in working capital | 18.13 Million | 37.99 Million | -24.82 Million | 11.03 Million | 3.7 Million | -8.19 Million |
| Other non-cash items | 128.68 Million | -6.27 Million | 75 Thousand | 44.28 Million | -4.6 Million | 1.35 Million |
| Investing Cash Flow | 31.99 Million | 73.24 Million | -71.1 Million | 192.5 Million | -165.83 Million | -71.48 Million |
| Investments in PPE | -40.05 Million | - | -1.12 Million | -7.58 Million | -1.12 Million | -2.14 Million |
| Acquisitions | -32.04 Million | - | 69.98 Million | -200.09 Million | 164.7 Million | 44 Thousand |
| Investment purchases | -369.98 Million | -363.17 Million | -492.79 Million | -339.9 Million | -578.63 Million | -331.06 Million |
| Sales/Maturities of investments | 442.03 Million | 436.41 Million | 422.81 Million | 540 Million | 413.92 Million | 261.67 Million |
| Other Investing Activities | 32.04 Million | 73.24 Million | -69.98 Million | 200.09 Million | -164.7 Million | 44 Thousand |
| Financing Cash Flow | 25.12 Million | 8.19 Million | 18.16 Million | 80.99 Million | 371.84 Million | 306.64 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 25.12 Million | 8.19 Million | 18.16 Million | 80.99 Million | 371.84 Million | 306.64 Million |
| Other Financing Activities | 25.12 Million | 8.19 Million | 18.16 Million | 80.99 Million | 371.84 Million | 306.64 Million |
| Accounts receivables | -39.27 Million | 2.17 Million | -16.11 Million | -12.46 Million | -9.69 Million | -8.74 Million |
| Accounts payables | 4.79 Million | 5.87 Million | -1.61 Million | 1.27 Million | 4.05 Million | -5.61 Million |
| Inventory | -28.8 Million | 2.41 Million | -4.21 Million | -3.32 Million | -1.73 Million | 1.92 Million |
| Other working capital | 81.41 Million | 27.53 Million | -2.87 Million | 25.55 Million | 11.07 Million | 4.24 Million |
| Cash at beginning of period | 114.84 Million | 153.2 Million | 331.79 Million | 194.46 Million | 139.58 Million | 71.89 Million |
| Cash at end of period | 188.65 Million | 120.61 Million | 153.2 Million | 331.79 Million | 194.46 Million | 139.58 Million |
| Capital Expenditure | -40.05 Million | - | -1.12 Million | -7.58 Million | -1.12 Million | -2.14 Million |
| Effect of forex changes on cash | -18 Thousand | 6000.00 | 7000.00 | -8000.00 | 2000.00 | 3000.00 |
| Net cash flow / Change in cash | 73.81 Million | -32.58 Million | -178.59 Million | 137.33 Million | 54.88 Million | 67.69 Million |
| Free Cash Flow | -23.34 Million | -114.03 Million | -126.78 Million | -143.75 Million | -152.25 Million | -169.61 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 33.38 Million | 16.55 Million | 45.79 Million | -61.28 Million | -65.17 Million | 1.11 Million |
| Depreciation & Amortization | 2.57 Million | 5.52 Million | 1.63 Million | 5.55 Million | 1.72 Million | 1.76 Million |
| Deferred income taxes | - | - | -38.94 Million | -140.8 Million | -50.07 Million | 16.12 Million |
| Stock-based compensation | 15.68 Million | 14.75 Million | 18.02 Million | 66.42 Million | 18.53 Million | 15.15 Million |
| Change in working capital | -24.67 Million | -5.96 Million | 21.71 Million | 18.13 Million | -10.55 Million | -9.58 Million |
| Other non-cash items | 55.78 Million | 36.6 Million | 37.17 Million | 128.68 Million | 46.58 Million | -16.37 Million |
| Investing Cash Flow | -56.19 Million | -14.03 Million | -347 Thousand | 31.99 Million | 34.11 Million | -194.28 Million |
| Investments in PPE | - | - | - | -40.05 Million | -50 Thousand | -40 Million |
| Acquisitions | - | - | - | -32.04 Million | 50 Thousand | 40 Million |
| Investment purchases | -137.69 Million | -80.15 Million | -104.1 Million | -369.98 Million | -37.2 Million | -161.78 Million |
| Sales/Maturities of investments | 81.5 Million | 66.11 Million | 103.76 Million | 442.03 Million | 71.36 Million | 7.5 Million |
| Other Investing Activities | -56.19 Million | -14.03 Million | -347 Thousand | 32.04 Million | -50 Thousand | -40 Million |
| Financing Cash Flow | 3.56 Million | 1.04 Million | 5.43 Million | 25.12 Million | 12.75 Million | 5.47 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 3.49 Million | - | - | - | - | - |
| Common Stock Issuance | 3.56 Million | 1.04 Million | 5.43 Million | 25.12 Million | 12.75 Million | 5.47 Million |
| Other Financing Activities | 3.56 Million | 1.04 Million | 5.43 Million | 25.12 Million | 12.75 Million | 5.47 Million |
| Accounts receivables | -10.31 Million | 3.56 Million | -7.81 Million | -39.27 Million | -10.95 Million | -15.93 Million |
| Accounts payables | 550 Thousand | 1.78 Million | 5.23 Million | 4.79 Million | -6.5 Million | 1.38 Million |
| Inventory | -27.14 Million | -16.64 Million | -15.06 Million | -28.8 Million | -11.22 Million | -3 Million |
| Other working capital | 12.23 Million | 6.62 Million | 39.36 Million | 81.41 Million | 18.11 Million | 7.96 Million |
| Cash at beginning of period | 204.74 Million | 194.42 Million | 98.19 Million | 114.84 Million | 116.06 Million | 296.66 Million |
| Cash at end of period | 177.13 Million | 210.51 Million | 188.65 Million | 188.65 Million | 103.96 Million | 116.06 Million |
| Capital Expenditure | - | - | - | -40.05 Million | -50 Thousand | -40 Million |
| Effect of forex changes on cash | 3000.00 | 5000.00 | -12 Thousand | -18 Thousand | -4000.00 | 199.63 Million |
| Net cash flow / Change in cash | -27.61 Million | 16.08 Million | 90.46 Million | 73.81 Million | -12.09 Million | -180.6 Million |
| Free Cash Flow | 25.01 Million | 29.07 Million | 85.38 Million | -23.34 Million | -59 Million | -31.79 Million |
NETLINK
CRI
ACQ
002938
TRN
PDRX